spacer
home > epc > summer 2002 > the trials and tribulations of importing clinical trials materials into europe
PUBLICATIONS
European Pharmaceutical Contractor

The Trials and Tribulations of Importing Clinical Trials Materials into Europe

There are a number of key areas that international pharmaceutical companies will need to consider when planning to conduct clinical studies in Europe. Perhaps most importantly, companies need to be aware of several forthcoming regulatory changes, which will be implemented in the next three years as a result of the adoption of the Clinical Trial Directive (2001/20/EC of the European Parliament and of the Council).

Currently, there is no unified regulation governing the import and movement of material around Europe. Local country regulations apply, which in some countries can be as simple as a notification, while in others a formal application is needed. In the UK, for example, all the details of the study materials would be included in the CTX application.

In general terms, the manufacture of clinical materials is not presently required to comply with GMP, but there are some notable exceptions - Germany, for instance, which applies the same GMP to clinical trial materials (CTM) as to a marketed product.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Keren Winmill, Director of Clinical Trial Supplies at Penn Pharmaceutical Services

Keren Winmill is a Pharmacist with 24 years of experience in the pharmaceutical industry. She joined Penn Pharmaceutical Services in 1990 to manage the clinical supplies unit. Keren spent 12 years with Ciba Geigy in Switzerland and in the UK in regulatory affairs, business development and marketing positions.

Keren subsequently joined Quintiles as Director of Business Development, returning to Penn in 1999 as Director of the Clinical Supplies Business Unit. She is responsible for clinical trial packaging and supply management.

spacer
Keren Winmill
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AstroNova introduces its range of grass paper labels derived from grass for high quality organic products

Dietzenbach, 29 April 2019, AstroNova GmbH, European headquarters of AstroNova Inc. (RI, USA), responsible for Sales and Customer Service in Europe, the Middle East and Africa (EMEA), is extending its Product Identification range with new approved labelling for direct foodstuff contact.
More info >>

White Papers

Speciality Logistics Outlook 2015

World Courier

To date, there are more than 178,000 registered clinical trials taking place across the globe, and global pharma’s volume has more than doubled over the last decade. With emerging markets showing explosive predictive growth through 2016, shippers and trial sponsors can expect continued regulatory and overall logistics complexities that foster demand for local, inmarket resources across the globe.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement